GO:0001556 oocyte maturation: Developmental Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001556 oocyte maturation is the developmental process, independent of morphogenetic shape change, that enables an oocyte to attain its fully functional state, beginning after meiotic reinitiation (commonly germinal vesicle breakdown) and continuing to the second meiotic arrest before fertilization.
• Oocyte maturation is not simply meiotic progression; it integrates nuclear and cytoplasmic maturation, including cytoplasmic polyadenylation of stored maternal mRNAs that drives translational activation.
• Competence to mature is acquired during follicular growth and is controlled by follicular cells and molecules present in follicular fluid.
• Defects in oocyte maturation are linked to embryonic failure, reduced ovum quality, and infertility, making it a central topic in reproductive biology and fertility preservation.
• In vitro maturation (IVM) of immature oocytes is an emerging clinical and experimental approach, including for cancer patients undergoing ovarian tissue cryopreservation.
• Studying oocyte maturation requires combining meiotic staging, RNA/translation assays, imaging, and CRISPR-based functional models to test causal gene roles.
Description
Oocyte maturation (GO:0001556) is a biological process that allows an oocyte to become fully functional, independent of morphogenetic shape change. It begins after meiosis is reinitiated, commonly marked by germinal vesicle breakdown, and proceeds to the second meiotic arrest that occurs before fertilization. This process is essential for producing an egg capable of supporting fertilization and early embryonic development. Researchers study oocyte maturation because failures in this process are associated with embryonic failure and poor reproductive outcomes. In domestic and model species, oocyte maturation is also a key determinant of ovum quality, with direct implications for assisted reproduction and livestock breeding. The process is not only nuclear; it includes cytoplasmic maturation events such as the storage, polyadenylation, and translation of maternal mRNAs that prepare the oocyte for early development. Because oocyte maturation competence is acquired during follicular growth and is influenced by follicular cells and follicular fluid molecules, it sits at the intersection of endocrine, paracrine, and cell-intrinsic regulation. Understanding GO:0001556 therefore matters for reproductive medicine, fertility preservation, and basic developmental biology.
oocyte maturation At A Glance
| GO ID | GO:0001556 |
|---|---|
| GO term | oocyte maturation |
| Ontology | biological_process |
| Synonym | none listed |
| Definition | A developmental process, independent of morphogenetic (shape) change, that is required for an oocyte to attain its fully functional state; commences after reinitiation of meiosis, commonly starting with germinal vesicle breakdown, and continues up to the second meiotic arrest prior to fertilization. |
| Major function | Nuclear and cytoplasmic maturation of the oocyte, including meiotic progression and preparation for fertilization and early development. |
| Process context | Occurs during follicular growth and is influenced by follicular cells and follicular fluid molecules. |
| Clinical relevance | Defects are linked to embryonic failure, reduced ovum quality, and infertility; IVM is used in fertility preservation. |
What Is GO:0001556?
According to the QuickGO definition, oocyte maturation (GO:0001556) is a developmental process, independent of morphogenetic (shape) change, that is required for an oocyte to attain its fully functional state. It commences after reinitiation of meiosis, commonly starting with germinal vesicle breakdown, and continues up to the second meiotic arrest prior to fertilization. In other words, it is the set of nuclear and cytoplasmic events that convert a growing oocyte into a mature egg competent for fertilization and early embryogenesis.
Why Is oocyte maturation Important in Cell Biology?
Oocyte maturation is important because it determines whether an oocyte can support fertilization and normal embryonic development, and its failure is associated with embryonic failure and poor ovum quality. Because maturation competence is acquired during follicular growth and is regulated by follicular cells and follicular fluid molecules, it is a focal point for understanding ovarian physiology and for improving assisted reproduction. In clinical settings, in vitro maturation of immature oocytes is increasingly relevant for fertility preservation, including in cancer patients undergoing ovarian tissue cryopreservation.
• Oocyte maturation is required for the oocyte to reach a fully functional state capable of fertilization.
• Failures in oocyte maturation are associated with embryonic failure and poor reproductive outcomes.
• Ovum quality in species such as pigs depends on successful oocyte maturation.
• Cytoplasmic polyadenylation during maturation controls translation of stored maternal mRNAs needed for early development.
• Maturation competence is acquired during follicular growth and is regulated by follicular cells and follicular fluid molecules.
• In vitro maturation of immature oocytes is used for fertility preservation, including in cancer patients.
• Oocyte maturation is studied in the context of in vitro fertilization and embryonic growth.
• Understanding maturation competencies helps define oocyte quality and developmental potential.
What Happens During oocyte maturation?
Reinitiation of meiosis and germinal vesicle breakdown
In simple terms: The oocyte restarts the cell division process that was paused, and its nucleus envelope breaks down.
Oocyte maturation commences after reinitiation of meiosis, commonly starting with germinal vesicle breakdown, and continues up to the second meiotic arrest prior to fertilization. This transition marks the entry into the maturation phase and is a defining step of GO:0001556.
Acquisition of maturation competence during follicular growth
In simple terms: The oocyte becomes ready to mature while it is still growing inside the follicle.
Maturation competence is acquired during follicular growth and is controlled by follicular cells and molecules present in follicular fluid. The origins and manifestations of these competencies determine whether an oocyte can complete maturation successfully.
Cytoplasmic maturation and maternal mRNA regulation
In simple terms: The oocyte's cytoplasm prepares stored instructions for use after fertilization.
Cytoplasmic maturation involves the storage and regulated translation of maternal mRNAs, including cytoplasmic polyadenylation, which is a key mechanism in mammalian oocyte maturation. This prepares the oocyte for the transition to embryonic development.
Progression to second meiotic arrest
In simple terms: The oocyte pauses again at a specific stage, waiting for fertilization.
Maturation continues up to the second meiotic arrest prior to fertilization, which is the endpoint of GO:0001556 as defined. This arrest is a normal and necessary state before fertilization occurs.
In vitro maturation as an experimental and clinical model
In simple terms: Scientists can mature oocytes outside the body to study and use them.
In vitro maturation of immature oocytes is used experimentally and clinically, including for fertility preservation in cancer patients undergoing ovarian tissue cryopreservation. Oocyte maturation, fertilization, and embryonic growth can be studied in vitro, providing a controlled system to analyze this process.
Key Genes Involved in GO:0001556 oocyte maturation
The following genes and proteins have been implicated in oocyte maturation processes in the cited literature, including meiotic progression, cytoplasmic polyadenylation, and follicular regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MOS | Meiotic progression regulator | Studied in oocyte maturation and meiotic arrest |
| MAPK1 | Signaling in meiotic progression | Implicated in oocyte maturation control |
| MAPK3 | Signaling in meiotic progression | Implicated in oocyte maturation control |
| CDK1 | Meiotic kinase driving maturation | Central to meiotic progression in oocytes |
| CCNB1 | Regulatory subunit of CDK1 | Controls meiotic progression during maturation |
| BMP15 | Follicular regulation of maturation | Influences oocyte maturation competence |
| GDF9 | Follicular regulation of maturation | Influences oocyte maturation competence |
| FSHR | Follicular cell signaling | Mediates follicular control of oocyte maturation |
| LHCGR | Follicular cell signaling | Mediates follicular control of oocyte maturation |
| PABPC1 | Cytoplasmic polyadenylation | Involved in maternal mRNA regulation during maturation |
| CPEB1 | Cytoplasmic polyadenylation | Regulates translation of stored maternal mRNAs |
| PAPOLA | Poly(A) tail synthesis | Contributes to cytoplasmic polyadenylation |
| ZAR1 | Maternal mRNA regulation | Studied in oocyte maturation and early development |
| NLRP5 | Maternal mRNA regulation | Studied in oocyte maturation and early development |
| BTG4 | Maternal mRNA regulation | Studied in oocyte maturation and early development |
| CNOT6L | Maternal mRNA deadenylation | Studied in oocyte maturation and early development |
| BUB1 | Spindle assembly checkpoint | Relevant to meiotic progression in oocytes |
How Is oocyte maturation Regulated?
Oocyte maturation is regulated by follicular cells and molecules present in follicular fluid, which control the acquisition of maturation competence during follicular growth. Cytoplasmic polyadenylation provides an additional layer of regulation by controlling the translation of stored maternal mRNAs during maturation. Meiotic progression itself is regulated by signaling pathways that govern reinitiation of meiosis and progression to the second meiotic arrest.
oocyte maturation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BMP15 | Ovarian dysfunction and infertility | Knockout or point-mutation cell model |
| GDF9 | Ovarian dysfunction and infertility | Knockout or point-mutation cell model |
| CPEB1 | Maternal mRNA regulation in infertility | Knockout or tagged knock-in model |
| PABPC1 | Cytoplasmic polyadenylation defects | Knockout or overexpression model |
| MAPK1 | Meiotic progression defects | Point-mutation or knockout model |
Infertility and embryonic failure
Defects in oocyte maturation are associated with embryonic failure and poor reproductive outcomes, making this process a key focus in infertility research. Ovum quality, which depends on successful maturation, is a determinant of fertility in species such as pigs.
Cancer and fertility preservation
For cancer patients undergoing ovarian tissue cryopreservation, in vitro maturation of immature oocytes is a strategy to preserve fertility, directly linking oocyte maturation biology to clinical oncology care.
Assisted reproduction and in vitro fertilization
Oocyte maturation, fertilization, and embryonic growth can be studied and manipulated in vitro, which is central to assisted reproduction technologies. Understanding maturation competencies helps assess oocyte quality and developmental potential in these settings.
From oocyte maturation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for meiotic progression? | Knockout cell model |
| Does a specific variant alter maturation signaling? | Point-mutation knock-in model |
| Where and when is a protein expressed during maturation? | Tagged knock-in model |
| Does overexpression of a gene accelerate or block maturation? | Overexpression cell model |
| Which genes are essential for cytoplasmic polyadenylation? | Knockout and rescue model |
| Can a candidate gene restore maturation in a deficient background? | Knock-in rescue model |
How to Study the oocyte maturation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Meiotic staging | Germinal vesicle breakdown and meiotic progression | Assessing oocyte maturation status |
| In vitro maturation | Ability of immature oocytes to mature in culture | Fertility preservation and basic research |
| Poly(A) tail assay | Cytoplasmic polyadenylation of maternal mRNAs | Studying translational regulation during maturation |
| RNA-seq | Transcript abundance changes during maturation | Identifying maturation-associated gene expression |
| Immunofluorescence imaging | Protein localization during meiotic progression | Visualizing spindle and nuclear events |
| Co-culture with follicular cells | Effect of follicular cells on maturation | Dissecting follicular regulation |
| Follicular fluid treatment | Effect of fluid molecules on maturation | Identifying paracrine regulators |
Meiotic staging and morphological assessment
Oocyte maturation can be assessed by tracking germinal vesicle breakdown and progression to the second meiotic arrest, which are defining events of GO:0001556. Morphological and developmental assessments are used to evaluate oocyte quality and maturation success.
RNA and translation assays
Because cytoplasmic polyadenylation regulates maternal mRNA translation during maturation, RNA-level and poly(A) tail assays are used to study this process. These approaches help determine how stored mRNAs are activated during oocyte maturation.
In vitro maturation systems
In vitro maturation of immature oocytes provides a controlled experimental system to study oocyte maturation, fertilization, and early embryonic growth. This approach is also used clinically for fertility preservation.
Follicular cell and follicular fluid studies
Since follicular cells and follicular fluid molecules control oocyte growth and maturation, co-culture and conditioned-medium experiments are used to dissect these regulatory interactions. Such studies help define how the follicular environment influences maturation competence.
How CRISPR Can Be Used to Study GO:0001556 oocyte maturation
Knockout
CRISPR knockout models can be used to test whether candidate genes are required for oocyte maturation, including meiotic progression and cytoplasmic maturation. By removing a gene, researchers can assess loss of maturation competence in a controlled system.
Point Mutation
Point-mutation models allow study of specific variants in genes implicated in oocyte maturation, such as those affecting signaling or mRNA regulation. These models help distinguish gain-of-function from loss-of-function effects on maturation.
Knock-in
Knock-in models can be used to tag or replace genes involved in oocyte maturation, enabling tracking of protein localization and function during meiotic progression. They also allow rescue experiments to confirm causality.
Overexpression
Overexpression models can test whether increased levels of a candidate gene accelerate, block, or otherwise alter oocyte maturation. Such experiments complement knockout studies by revealing dosage-sensitive effects.
How EDITGENE Supports oocyte maturation Research
Researchers studying oocyte maturation-related genes often need to determine whether a candidate gene is causally involved in meiotic progression, cytoplasmic maturation, or follicular regulation. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses in a rigorous, reproducible manner.
Contact EDITGENE today to design your custom CRISPR model for oocyte maturation research.
Frequently Asked Questions About oocyte maturation
What is oocyte maturation (GO:0001556)?
Oocyte maturation is a developmental process, independent of morphogenetic shape change, that is required for an oocyte to attain its fully functional state; it begins after reinitiation of meiosis, commonly with germinal vesicle breakdown, and continues to the second meiotic arrest before fertilization.
What happens during oocyte maturation?
During oocyte maturation, meiosis is reinitiated, germinal vesicle breakdown occurs, cytoplasmic maturation including maternal mRNA regulation takes place, and the oocyte progresses to the second meiotic arrest prior to fertilization.
What genes are involved in oocyte maturation?
Genes implicated in oocyte maturation include meiotic regulators such as MOS, MAPK1, MAPK3, CDK1, and CCNB1, follicular regulators such as BMP15 and GDF9, and cytoplasmic polyadenylation factors such as CPEB1 and PABPC1.
Why is oocyte maturation important for fertility?
Oocyte maturation determines whether an oocyte can support fertilization and early development; defects are associated with embryonic failure and poor ovum quality.
How is oocyte maturation studied in the lab?
Oocyte maturation is studied using meiotic staging, in vitro maturation systems, RNA and polyadenylation assays, imaging, and co-culture with follicular cells or follicular fluid.
What is in vitro maturation of oocytes?
In vitro maturation is the process of maturing immature oocytes outside the body, used both experimentally and clinically, including for fertility preservation in cancer patients.
How do follicular cells regulate oocyte maturation?
Follicular cells and molecules in follicular fluid control oocyte growth and maturation, influencing the acquisition of maturation competence.
What is the role of cytoplasmic polyadenylation in oocyte maturation?
Cytoplasmic polyadenylation regulates the translation of stored maternal mRNAs during mammalian oocyte maturation, preparing the oocyte for early development.
Can CRISPR be used to study oocyte maturation genes?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models can be used to test the causal roles of genes in oocyte maturation.
What is the endpoint of oocyte maturation?
Oocyte maturation continues up to the second meiotic arrest prior to fertilization, which is the endpoint defined for GO:0001556.
Conclusion
GO:0001556 oocyte maturation is a fundamental developmental process that prepares the oocyte for fertilization and early embryogenesis through meiotic progression and cytoplasmic maturation. Its regulation by follicular cells and follicular fluid molecules, and its association with embryonic failure and ovum quality, make it a central topic in reproductive biology and medicine. Continued research using in vitro maturation systems and CRISPR-based models will help clarify the genetic and molecular control of this process and improve fertility preservation and assisted reproduction.
References
- 1. Moor RM et al.. 1998. Oocyte maturation and embryonic failure.. Hum Reprod Update 4(3):223-36 PMID: 9741707
- 2. Hunter MG. 2000. Oocyte maturation and ovum quality in pigs.. Rev Reprod 5(2):122-30 PMID: 10864857
- 3. Mohd Faizal A et al.. 2022. Twenty-first century oocyte cryopreservation-in vitro maturation of immature oocytes from ovarian tissue cryopreservation in cancer patients: A systematic review.. Womens Health (Lond) 18:17455057221114269 PMID: 35983837
- 4. Reyes JM et al.. 2016. Cytoplasmic polyadenylation in mammalian oocyte maturation.. Wiley Interdiscip Rev RNA 7(1):71-89 PMID: 26596258
- 5. Segers I et al.. 2024. Ovarian Tissue Oocyte-In Vitro Maturation for Fertility Preservation.. J Vis Exp PMID: 38829044
- 6. Plachot M et al.. 1990. Oocyte maturation, fertilization and embryonic growth in vitro.. Br Med Bull 46(3):675-94 PMID: 2207600
- 7. Albertini DF et al.. 2003. Origins and manifestations of oocyte maturation competencies.. Reprod Biomed Online 6(4):410-5 PMID: 12831584
- 8. Driancourt MA et al.. 1998. Control of oocyte growth and maturation by follicular cells and molecules present in follicular fluid. A review.. Reprod Nutr Dev 38(4):345-62 PMID: 9795980
